NCT02668510

RCT Comparing ESWT With PRP for Plantar Fasciitis in High Demand Cohort

A Randomized Controlled Pilot Trial Comparing Extracorporeal Shock Wave Therapy With Platelet Rich Plasma Versus Extracorporeal Shock Wave Therapy in a High Demand Cohort With Resistant Plantar Fasciitis

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Edna Rath · Federal
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

A Randomized Controlled Pilot Trial Comparing Extracorporeal Shock Wave Therapy with Platelet Rich Plasma versus Extracorporeal Shock Wave Therapy in a High Demand Cohort with Resistant Plantar Fasciitis

Detailed description

The purpose of this proposal is to perform a high-quality pilot study testing the efficacy of ESWT in combination with PRP for the management of resistant plantar fasciitis. We endeavor to determine if the pilot evidence supports a large, randomized study; and to conduct a power analysis for the follow-on study. The proposed pilot study will be a prospective double-blinded randomized controlled trial comparing pain and functionality at the 3 week, 6 week, 12 week and 6 month marks between extracorporeal shock wave therapy (ESWT) with platelet rich plasma (PRP) injection versus extracorporeal shock wave therapy with placebo injection of normal saline.

Conditions

• Fasciitis, Plantar

Interventions

Type	Name	Description
BIOLOGICAL	platelet rich plasma	immediately following shockwave therapy the injection of PRP derived from subjects own blood using Arthex double syringe system will be injected at the origin of the plantar fascia at the calcaneous
DRUG	Normal saline	placebo injection of normal saline immediately following shockwave therapy

Timeline

• Start date: 2016-01-01
• Primary completion: 2023-12-11
• Completion: 2023-12-11
• First posted: 2016-01-29
• Last updated: 2025-09-25

Locations

1 site across 1 country: United States